1. Home
  2. BRCB vs SGHT Comparison

BRCB vs SGHT Comparison

Compare BRCB & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRCB

Black Rock Coffee Bar Inc.

HOLD

Current Price

$7.20

Market Cap

206.8M

Sector

N/A

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.19

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCB
SGHT
Founded
2008
2011
Country
United States
United States
Employees
2800
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
235.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BRCB
SGHT
Price
$7.20
$5.19
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$24.83
$9.08
AVG Volume (30 Days)
388.6K
324.5K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
$30.74
$11.67
Revenue Next Year
$24.06
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.61
$3.11
52 Week High
$30.40
$9.24

Technical Indicators

Market Signals
Indicator
BRCB
SGHT
Relative Strength Index (RSI) 19.44 63.62
Support Level N/A $4.86
Resistance Level $15.72 $5.25
Average True Range (ATR) 0.81 0.37
MACD -0.44 0.08
Stochastic Oscillator 1.76 74.05

Price Performance

Historical Comparison
BRCB
SGHT

About BRCB Black Rock Coffee Bar Inc.

Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: